In silico assessment of the effects of various compounds in MEA/hiPSC-CM assays: Modeling and numerical simulations

Blazeski, 2012, Electrophysiological and contractile function of cardiomyocytes derived from human embryonic stem cells, Progress in Biophysics and Molecular Biology, 110, 178, 10.1016/j.pbiomolbio.2012.07.012 Bottino, 2006, Preclinical cardiac safety assessment of pharmaceutical compounds using an integrated systems-based computer model of the heart, Progress in Biophysics and Molecular Biology, 90, 414, 10.1016/j.pbiomolbio.2005.06.006 Boulakia, 2015, Toward transmembrane potential estimation from in vitro multi-electrode field potentials using mathematical modeling, Journal of Pharmacological and Toxicological Methods, 75, 168, 10.1016/j.vascn.2015.08.038 Bowler, 2016, Simulated micro-electrode array recordings from stem cell-derived cardiomyocytes, Journal of Pharmacological and Toxicological Methods, 81, 380, 10.1016/j.vascn.2016.02.148 Braam, 2010, Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes, Stem Cell Research, 4, 107—11 6, 10.1016/j.scr.2009.11.004 Brennan, 2009, Multiscale modelling of drug-induced effects on cardiac electrophysiological activity, European Journal of Pharmaceutical Sciences, 36, 62, 10.1016/j.ejps.2008.09.013 Bucchi, 2013, Identification of the molecular site of ivabradine binding to hcn4 channels, PloS One, 8, e53132, 10.1371/journal.pone.0053132 Carmeliet, 1998, Antiarrhythmic drugs and cardiac ion channels: Mechanisms of action, Progress in Biophysics and Molecular Biology, 70, 1, 10.1016/S0079-6107(98)00002-9 Caspi, 2009, In vitro electrophysiological drug testing using human embryonic stem cell derived cardiomyocytes, Stem Cells and Development, 18, 161, 10.1089/scd.2007.0280 Cavero, 2016, Comprehensive in vitro Proarrhythmia Assay (CiPA): Pending issues for successful validation and implementation, Journal of Pharmacological and Toxicological Methods, 10.1016/j.vascn.2016.05.012 Pavarino, 2014, Vol. 13 Doss, 2012, Maximum diastolic potential of human induced pluripotent stem cell-derived cardiomyocytes depends critically on ikr, PloS One, 7, e40288, 10.1371/journal.pone.0040288 Gulrajani, 2001, A membrane-based computer heart model employing parallel processing, Biomedizinische Technik/Biomedical Engineering, 46, 20, 10.1515/bmte.2001.46.s2.20 Harris, 2013, Comparison of electrophysiological data from human-induced pluripotent stem cell-derived cardiomyocytes to functional preclinical safety assays, Toxicological Sciences, 10.1093/toxsci/kft113 He, 2003, Human embryonic stem cells develop into multiple types of cardiac myocytes action potential characterization, Circulation Research, 93, 32, 10.1161/01.RES.0000080317.92718.99 Hille, 2001, Vol. 507 Laflamme, 2007, Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts, Nature Biotechnology, 25, 1 015—1024, 10.1038/nbt1327 Mangi, 2003, Mesenchymal stem cells modified with akt prevent remodeling and restore performance of infarcted hearts, Nature Medicine, 9, 1195—1 201, 10.1038/nm912 Mirams, 2011, Simulation of multiple ion channel block provides improved early prediction of compounds clinical torsadogenic risk, Cardiovascular Research, 91, 53, 10.1093/cvr/cvr044 Mirams, 2012, Application of cardiac electrophysiology simulations to pro-arrhythmic safety testing, British Journal of Pharmacology, 167, 932, 10.1111/j.1476-5381.2012.02020.x Moulin, 2008, A new 3-D finite-element model based on thin-film approximation for microelectrode array recording of extracellular action potential, Biomedical Engineering, IEEE Transactions on, 55, 683, 10.1109/TBME.2007.903522 Multichannel systems, Microelectrode array (mea) manual. http://www.multichannelsystems.com/sites/multichannelsystems.com/files/documents/manuals/MEA_Manual.pdf. Paci, 2013, Computational models of ventricular- and atrial-like human induced pluripotent stem cell derived cardiomyocytes, Annals of Biomedical Engineering, 41, 2334, 10.1007/s10439-013-0833-3 Paci, 2014, Computational modeling supports induced pluripotent stem cell-derived cardiomyocytes reliability as a model for human lqt3, 69 Pekkanen-Mattila, 2010, Human embryonic stem cell-derived cardiomyocytes: Demonstration of a portion of cardiac cells with fairly mature electrical phenotype, Experimental Biology and Medicine, 235, 522, 10.1258/ebm.2010.009345 Peng, 2010, The action potential and comparative pharmacology of stem cell-derived human cardiomyocytes, Journal of Pharmacological and Toxicological Methods, 61, 277, 10.1016/j.vascn.2010.01.014 Qu, 2015, Proarrhythmia risk assessment in human induced pluripotent stem cell-derived cardiomyocytes using the maestro mea platform, Toxicological Sciences, 147, 286, 10.1093/toxsci/kfv128 Robertson, 2013, Concise review: Maturation phases of human pluripotent stem cell-derived cardiomyocytes, Stem Cells, 31, 829, 10.1002/stem.1331 Sundnes, 2007, Vol. 1 Sundnes, 2005, An operator splitting method for solving the bidomain equations coupled to a volume conductor model for the torso, Mathematical Biosciences, 194, 233, 10.1016/j.mbs.2005.01.001 Takahashi, 2006, Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors, Cell, 126, 663, 10.1016/j.cell.2006.07.024 Zahradníková, 2007, Competitive and cooperative effects of bay k8644 on the l-type calcium channel current inhibition by calcium channel antagonists, Journal of Pharmacology and Experimental Therapeutics, 322, 638, 10.1124/jpet.107.122176 Zemzemi, 2013, Computational assessment of drug-induced effects on the electrocardiogram: From ion channel to body surface potentials, British Journal of Pharmacology, 168, 718, 10.1111/j.1476-5381.2012.02200.x Zemzemi, 2015, Effects of L-type calcium channel and human ether-a-go-go related gene blockers on the electrical activity of the human heart: A simulation study, Europace, 17, 326, 10.1093/europace/euu122